Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
Description
CONCLUSION: Our study concluded that DIP has a potential therapeutic effect in the management and treatment of Covid-19. This could be attained either directly, through anti-SARS-CoV-2, anti-inflammatory, and anti-platelets properties, or indirectly
